Mesenchymal stromal cells (MSCs) established by in-vitro adherence culture have been widely utilized for various cell therapeutic trials, but potential heterogeneity that can be caused by preparation methods are poorly characterized. In this study, we show that at least two distinct subsets of MSCs with different adherence to plastic surface exist in human adipose tissue-derived stromal vascular fraction (SVF); while 69% of total colony forming units in SVF adhere to the surface before 3 hrs of plating, 13-17% of colonogenic cells adhered to the surface at later period of 15 hr to 1 week after plating. Of note, the late adherent MSCs exhibited higher self-renewal of colony forming cells and higher proliferating potential with comparable level of osteogenic or adipogenic differentiation potential to the early adherence subsets. Moreover, late adherent cells exhibited distinct pattern of paracrine secretome including higher level secretion of cytokines than the early adherent subsets. Taken together, these results suggest the possibility that distinct adherence properties of MSCs can be another parameter of clonal heterogeneity in the subpopulations of adipose tissue MSCs and that it can be an important factor for optimization of MSC preparation for cell therapeutic trials.
INTRODUCTION
Mesenchymal stromal cells (MSCs) are non-hematopoietic adherent cell populations that can be obtained from various tissues including bone marrow (BM), adipose tissue, or placental tissue. These MSCs exhibit multi-lineage differentiation potential towards diverse types of tissues including bone, cartilage, adipose tissues [1, 2] . Recent studies have shown that the primary mode of action for MSCs is the establishment of a regenerative microenvironment in response to tissue injury, thereby stimulating the regeneration of hematopoietic stem cells, neuronal stem cells, and other tissue-specific stem cells [3] [4] [5] . Principal function of the MSCs to establish regenerative microenvironment are exerted via paracrine secretion of various growth factors that can stimulate angiogenesis and inhibit apoptosis and fibrosis [6] .
While the MSCs can be derived from various types of tissues, studies have shown that MSCs from diverse sources nevertheless share several common surface phenotypes: these include the expression of CD90 (Thy-1), CD166 (SB10/ALCAM), CD73 (SH3), CD105 (SH2, endoglin), and the primitive subpopulation of MSCs have been identified by specific surface markers such as CD271 or CD146 [7, 8] . On the other hand, studies have shown that considerable extent of heterogeneity can be caused in the subsets of MSCs depending on the methods of preparations or in-vitro expansion culture conditions culture [9, 10] , suggesting the need for optimization of process for MSC preparations for cell therapy.
Of note, most of MSC cultures are established by adherence to the plastic surface, but various approaches have been described to obtain the adherent populations. For example, traditional MSC populations were prepared by plating total mononuclear cells of BM or stromal vascular fraction (SVF) of adipose tissue in the plastic culture dish and by harvesting total adherent cell populations. On the other hand, recent studies reported a protocol where murine MSCs can be prepared from BM by 3 hr short-term plating of total BM cells thus harvesting the early adherent cell population [11, 12] . In contrast, Song et al. [13] have reported preparation of clonal MSCs by serial fractionation of the BM mononuclear cells. However, it has not been clear yet whether these differences in the preparation methods of the MSCs could be related to the difference in their characteristics in MSC function or in their cell therapeutic function. 
Distinct secretome pattern of early and late adherent MSC subpopulations
Next, to see if potential distinction exists in the secretory activity of bioactive factors among the MSC subpopulations, we compared the secretome in the protein array blot between the early and late adherent population. As shown in Figure 6 , for most of the secretory factors examined, the late adherent (15 hr or 1 week) MSCs exhibited higher level secretion of the factors than early (3 hr) adherent populations, including higher level of IL-6, IL-1RA or basic fibroblast growth factor. These results show that the early and late adherent populations also exhibit difference in the paracrine secretion pattern with distinct levels of cytokine secretion. Taken together, our results show that while most of the ADSC can be quantitatively harvested by short-term incubation for 3 hrs, minor subpopulation of adipose-derived MSCs with higher proliferation, self-renewal and higher secretory activities can reside in the late adherent cell populations.
DISCUSSION
MSCs have been obtained by in-vitro culture of adherent stromal cell populations contained in various tissues including BM, adipose tissues or placenta. These culture-expanded MSCs from various types of tissues share certain extent of biological properties such as common surface markers and paracrine secretion of bioactive peptides in the injured tissues, facilitating the establishment of regenerative microenvironment in the tissue injury condition [6] . Recently, the ex-vivo expanded MSCs has been widely used in a variety of cell therapeutic trials that includes regeneration of damaged cardiovascular [16] , neural [17] and muscular-skeletal tissues [18] [19] [20] [21] as well as for the suppression of allogenic immune reactions [22, 23] for facilitation of hematopoietic engraftment [14, 24] .
However, despite many of common properties in MSCs such as surface phenotype and their biological characteristics, significant heterogeneity was also observed among the subpopulation of MSC preparation in the morphology, proliferation and differentiation potentials [25] [26] [27] as well as in their cell size or self-renewing potential [25, 28] .
While the cellular bases for such heterogeneity of MSCs are not clear yet. it has been pointed that initial cell populations in BM or adipose tissue SVF are heterogeneous [29] and significant extent of heterogeneity can be caused by difference in the methods of preparation and in-vitro culture [9, 10] .
So far, MSCs have been prepared in a conventional adherence to the plastic surface. Recently, a guideline protocol was suggested for efficient preparation of MSCs in the murine BM model [11, 12] , where BM mononuclear cells are selected by adherence to the plastic dish for 3 hrs after plating. On the other hand, other study showed that human BM-derived MSCs can be established by serial subfraction culture methods exhibiting considerable variations in epitopes, differentiation potential, and cytokine secretions [13] , suggesting the possibility that adherence to the plastic surface could constitute another parameter for heterogeneous subpopulation of MSCs.
In consistence to the possibility, our study show that at least two distinct subpopulations (early and late) exist in the adipose tissue SVF, and that these subsets can be separated by difference in their adherence time to the plastic surface. Our study showed that, while most of the mesenchymal CFU-F in adipose SVF were contained in the early adherent fraction, distinct subsets of MSCs can be obtained from late adherent populations in the SVF of human adipose tissues.
Of note, the subsets of MSCS with distinction in plastic adherence exhibited a series of distinct functional characteristics, i.e., the late adherent populations exhibited higher self-renewal and proliferative activity than the early adherent mesenchymal subsets. Moreover, these late-adherent MSC subsets also exhibited distinct cytokine secretion pattern from earlier adherent subsets, thus indicating that their paracrine activity for cell therapeutic action could be distinct. Thus, our study points to the possibility that the MSC populations can have different cell therapeutic outcomes caused by the cellular heterogeneity depending on the preparation of the mesenchymal culture. In coherence to the possibility, previous studies showed that the MSCs isolated by different methods exhibited differences in surface epitope, differentiation potential and immune modulating activities [30] as well as difference in their therapeutic function for immune suppression [31] .
However, it should be also mentioned that, while we have separated late adherent cells by collecting the cells non-adherent at 3 hr, but adherent during 15 hr to 1 week time points, we observed that significant extent of individual variations exist in the time for late adherence. Nevertheless, our study can provide an alternative model of MSC preparation in a manner that the late adherent cell populations excluding the 3 hr-adherent population (i.e., 15 hr to 1 week) are selectively expanded for higher proliferation and secretory activities of expanded cell products. Further studies on more numbers of individual fat tissues are necessary to set more detail cut-off time point for MSC subsets.
Taken together, our study show that the human adipose tissue SVF harbors heterogeneous subsets of MSCs that are distinct in their adherence kinetics and biological characteristics, and suggest that the optimization of the preparation methods are warranted for standardization of the MSC quality and their therapeutic outcomes in the cell therapeutic trials.
